Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03765567 · ClinicalTrials.gov registry record · Phase 4

Placement of Antibiotic Powder in Wounds During the Emergency Room

A Phase 4 study of Open Fracture, sponsored by The University of Texas Health Science Center at San Antonio.

Recruiting
Registry status
Phase 4
Development phase
200
Enrollment target
2
Study locations

NCT03765567 is a Phase 4 study of Open Fracture that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 200 participants. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03765567, a Phase 4 study of Open Fracture, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.

RECRUITING
Registry status
Phase 4
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

This is the first prospective controlled study to determine whether the topical application of vancomycin powder reduces infection-related complications when applied to open fracture injuries in the acute emergency department setting.

Conditions Studied

Interventions

  • DRUG Vancomycin

Study Locations (2)

Texas

  • University Hospital - San Antonio
  • San Antonio Military Medical Center - San Antonio

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2020-10-05
Est. Completion 2027-07
Phase Phase 4

What the Registry Record Tells You About NCT03765567

The ClinicalTrials.gov registry entry for NCT03765567 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Open Fracture appearing as the primary indexed condition, and to 1 intervention - of which Vancomycin is the first listed.

NCT03765567 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03765567 about?

NCT03765567 is a clinical study titled "Placement of Antibiotic Powder in Wounds During the Emergency Room". This is the first prospective controlled study to determine whether the topical application of vancomycin powder reduces infection-related complications when applied to open fracture injuries in the acute emergency department setting.

What is the current status of trial NCT03765567?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2020-10-05. Estimated completion is 2027-07.

What conditions does trial NCT03765567 study?

This clinical trial studies the following conditions: Open Fracture.

What interventions are being tested in trial NCT03765567?

The interventions under investigation include: Vancomycin (DRUG).

Who is sponsoring clinical trial NCT03765567?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03765567 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Open Fracture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.